CAS 1235449-52-1

BEBT-908

CAS : 1235449-52-1

BEBT-908

Degré de pureté : ≥98%

Masse moléculaire : 507.57g/mol

Ref: 54-BUP09236

BEBT-908

CAS : 1235449-52-1

BEBT-908 (PI3Kα inhibitor 1) is a selective PI3Kα inhibitor (IC50 <0.1 μM). BEBT-908 also inhibits HDAC (0.1 μM≤IC50≤1 μM).

Formule : C₂₃H₂₅N₉O₃S

Degré de pureté : 99.67%

Couleur et forme : Solid

Masse moléculaire : 507.57

Ref: TM-T16529

BEBT-908

CAS : 1235449-52-1

BEBT-908 is a potent inhibitor of the cell cycle that inhibits the proliferation of fibroblasts by blocking G1 phase and inducing apoptosis. BEBT-908 has been shown to have synergistic effects with other drugs, such as paclitaxel, cisplatin, or etoposide. It also exhibits cytotoxicity against cutaneous malignant cells in a dose-dependent manner. This drug has been hypothesized to have pharmacologic effects on extracellular matrix production and growth factor production.!--

Formule : C₂₃H₂₅N₉O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 507.57 g/mol

Ref: 3D-KZB44952